Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002736

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 29, 2014
Accepted (ET)
Mar 29, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 27, 2015P1,000$2.36A1,946,577ISee Footnote
Common StockF3May 27, 2015P1,000$2.36A1,420,694D
Common StockF1,F2May 29, 2015P3,180$2.30A1,949,757ISee Footnote
Common StockF3May 29, 2015P3,180$2.30A1,423,874D
Common StockF1,F2Oct 30, 2015P4,000$1.53A1,953,757ISee Footnote
Common StockF3Oct 30, 2015P4,000$1.53A1,427,874D
Common StockF1,F2Nov 30, 2015P900$1.24A1,954,657ISee Footnote
Common StockF3Nov 30, 2015P900$1.24A1,428,774D
Common StockF1,F2Dec 11, 2015P3,000$1.29A1,957,657ISee Footnote
Common StockF3Dec 11, 2015P3,000$1.29A1,431,774D
Common StockF1,F2Dec 14, 2015P5,000$1.47A1,962,657ISee Footnote
Common StockF3Dec 14, 2015P5,000$1.47A1,436,774D
Common StockF1,F2Dec 15, 2015P5,000$1.41A1,967,657ISee Footnote
Common StockF3Dec 15, 2015P5,000$1.41A1,441,774D
Common StockF1,F2Dec 17, 2015P2,000$1.43A1,969,657ISee Footnote
Common StockF3Dec 17, 2015P2,000$1.43A1,443,774D
Common StockF1,F2Dec 18, 2015P1,000$1.52A1,970,657ISee Footnote
Common StockF3Dec 18, 2015P1,000$1.52A1,444,774D
Common StockF1,F2Dec 21, 2015P3,000$1.53A1,973,657ISee Footnote
Common StockF3Dec 21, 2015P3,000$1.53A1,447,774D
Common StockF1,F2Dec 22, 2015P3,000$1.63A1,976,657ISee Footnote
Common StockF3Dec 22, 2015P3,000$1.63A1,450,774D
Common StockF1,F2Dec 23, 2015P200$1.66A1,976,857ISee Footnote
Common StockF3Dec 23, 2015P200$1.66A1,450,974D
Common StockF1,F2Dec 28, 2015P1,100$1.85A1,977,957ISee Footnote
Common StockF3Dec 28, 2015P1,100$1.85A1,452,074D
Common StockF1,F2Dec 28, 2015P10,000$1.76A1,987,957ISee Footnote
Common StockF3Dec 28, 2015P10,000$1.76A1,462,074D
Common StockF1,F2Dec 29, 2015P9,100$1.76A1,997,057ISee Footnote
Common StockF3Dec 29, 2015P9,100$1.76A1,471,174D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

(+) This is the third part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.